Abstract
Summary
β-Cyclodextrin is a cyclic derivative of starch prepared from partially hydrolyzed starch (maltodextrin) by an enzymatic process.β-Cyclodextrin is a new type of pharmaceutical for raw materials and food additives, it can be widely used in medicine, food, cosmetics, the light industry, agriculture and other areas.
LPI (LP Information)' newest research report, the “Beta-Cyclodextrin Industry Forecast” looks at past sales and reviews total world Beta-Cyclodextrin sales in 2022, providing a comprehensive analysis by region and market sector of projected Beta-Cyclodextrin sales for 2023 through 2029. With Beta-Cyclodextrin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Cyclodextrin industry.
This Insight Report provides a comprehensive analysis of the global Beta-Cyclodextrin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Cyclodextrin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Beta-Cyclodextrin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Cyclodextrin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Cyclodextrin.
The global Beta-Cyclodextrin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Beta-Cyclodextrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Beta-Cyclodextrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Beta-Cyclodextrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Beta-Cyclodextrin players cover Roquette, Nihon Shokuhin Kako, Shandong Xinda, Zibo Qianhui, Mengzhou Huaxing, Mengzhou Hongji, Zhiyuan Biotechnology, Jiyan Chemicals And Pharmaceuticals and W＆Z Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Cyclodextrin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
97%(Purity)
98%(Purity)
99%(Purity)
Segmentation by application
Food Industry
Pharmaceutical Industry
Cosmetics Industry
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roquette
Nihon Shokuhin Kako
Shandong Xinda
Zibo Qianhui
Mengzhou Huaxing
Mengzhou Hongji
Zhiyuan Biotechnology
Jiyan Chemicals And Pharmaceuticals
W＆Z Biotech
Henrikang Biotech
Cyclo Therapeutics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Beta-Cyclodextrin market?
What factors are driving Beta-Cyclodextrin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta-Cyclodextrin market opportunities vary by end market size?
How does Beta-Cyclodextrin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Beta-Cyclodextrin Industry Forecast” looks at past sales and reviews total world Beta-Cyclodextrin sales in 2022, providing a comprehensive analysis by region and market sector of projected Beta-Cyclodextrin sales for 2023 through 2029. With Beta-Cyclodextrin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Cyclodextrin industry.
This Insight Report provides a comprehensive analysis of the global Beta-Cyclodextrin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Cyclodextrin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Beta-Cyclodextrin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Cyclodextrin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Cyclodextrin.
The global Beta-Cyclodextrin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Beta-Cyclodextrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Beta-Cyclodextrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Beta-Cyclodextrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Beta-Cyclodextrin players cover Roquette, Nihon Shokuhin Kako, Shandong Xinda, Zibo Qianhui, Mengzhou Huaxing, Mengzhou Hongji, Zhiyuan Biotechnology, Jiyan Chemicals And Pharmaceuticals and W＆Z Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Cyclodextrin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
97%(Purity)
98%(Purity)
99%(Purity)
Segmentation by application
Food Industry
Pharmaceutical Industry
Cosmetics Industry
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roquette
Nihon Shokuhin Kako
Shandong Xinda
Zibo Qianhui
Mengzhou Huaxing
Mengzhou Hongji
Zhiyuan Biotechnology
Jiyan Chemicals And Pharmaceuticals
W＆Z Biotech
Henrikang Biotech
Cyclo Therapeutics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Beta-Cyclodextrin market?
What factors are driving Beta-Cyclodextrin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta-Cyclodextrin market opportunities vary by end market size?
How does Beta-Cyclodextrin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Beta-Cyclodextrin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Beta-Cyclodextrin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Beta-Cyclodextrin by Country/Region, 2018, 2022 & 2029
2.2 Beta-Cyclodextrin Segment by Type
2.2.1 97%(Purity)
2.2.2 98%(Purity)
2.2.3 99%(Purity)
2.3 Beta-Cyclodextrin Sales by Type
2.3.1 Global Beta-Cyclodextrin Sales Market Share by Type (2018-2023)
2.3.2 Global Beta-Cyclodextrin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Beta-Cyclodextrin Sale Price by Type (2018-2023)
2.4 Beta-Cyclodextrin Segment by Application
2.4.1 Food Industry
2.4.2 Pharmaceutical Industry
2.4.3 Cosmetics Industry
2.5 Beta-Cyclodextrin Sales by Application
2.5.1 Global Beta-Cyclodextrin Sale Market Share by Application (2018-2023)
2.5.2 Global Beta-Cyclodextrin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Beta-Cyclodextrin Sale Price by Application (2018-2023)
3 Global Beta-Cyclodextrin by Company
3.1 Global Beta-Cyclodextrin Breakdown Data by Company
3.1.1 Global Beta-Cyclodextrin Annual Sales by Company (2018-2023)
3.1.2 Global Beta-Cyclodextrin Sales Market Share by Company (2018-2023)
3.2 Global Beta-Cyclodextrin Annual Revenue by Company (2018-2023)
3.2.1 Global Beta-Cyclodextrin Revenue by Company (2018-2023)
3.2.2 Global Beta-Cyclodextrin Revenue Market Share by Company (2018-2023)
3.3 Global Beta-Cyclodextrin Sale Price by Company
3.4 Key Manufacturers Beta-Cyclodextrin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta-Cyclodextrin Product Location Distribution
3.4.2 Players Beta-Cyclodextrin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Beta-Cyclodextrin by Geographic Region
4.1 World Historic Beta-Cyclodextrin Market Size by Geographic Region (2018-2023)
4.1.1 Global Beta-Cyclodextrin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Beta-Cyclodextrin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Beta-Cyclodextrin Market Size by Country/Region (2018-2023)
4.2.1 Global Beta-Cyclodextrin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Beta-Cyclodextrin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Beta-Cyclodextrin Sales Growth
4.4 APAC Beta-Cyclodextrin Sales Growth
4.5 Europe Beta-Cyclodextrin Sales Growth
4.6 Middle East & Africa Beta-Cyclodextrin Sales Growth
5 Americas
5.1 Americas Beta-Cyclodextrin Sales by Country
5.1.1 Americas Beta-Cyclodextrin Sales by Country (2018-2023)
5.1.2 Americas Beta-Cyclodextrin Revenue by Country (2018-2023)
5.2 Americas Beta-Cyclodextrin Sales by Type
5.3 Americas Beta-Cyclodextrin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Cyclodextrin Sales by Region
6.1.1 APAC Beta-Cyclodextrin Sales by Region (2018-2023)
6.1.2 APAC Beta-Cyclodextrin Revenue by Region (2018-2023)
6.2 APAC Beta-Cyclodextrin Sales by Type
6.3 APAC Beta-Cyclodextrin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Beta-Cyclodextrin by Country
7.1.1 Europe Beta-Cyclodextrin Sales by Country (2018-2023)
7.1.2 Europe Beta-Cyclodextrin Revenue by Country (2018-2023)
7.2 Europe Beta-Cyclodextrin Sales by Type
7.3 Europe Beta-Cyclodextrin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Beta-Cyclodextrin by Country
8.1.1 Middle East & Africa Beta-Cyclodextrin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Beta-Cyclodextrin Revenue by Country (2018-2023)
8.2 Middle East & Africa Beta-Cyclodextrin Sales by Type
8.3 Middle East & Africa Beta-Cyclodextrin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta-Cyclodextrin
10.3 Manufacturing Process Analysis of Beta-Cyclodextrin
10.4 Industry Chain Structure of Beta-Cyclodextrin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta-Cyclodextrin Distributors
11.3 Beta-Cyclodextrin Customer
12 World Forecast Review for Beta-Cyclodextrin by Geographic Region
12.1 Global Beta-Cyclodextrin Market Size Forecast by Region
12.1.1 Global Beta-Cyclodextrin Forecast by Region (2024-2029)
12.1.2 Global Beta-Cyclodextrin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Beta-Cyclodextrin Forecast by Type
12.7 Global Beta-Cyclodextrin Forecast by Application
13 Key Players Analysis
13.1 Roquette
13.1.1 Roquette Company Information
13.1.2 Roquette Beta-Cyclodextrin Product Portfolios and Specifications
13.1.3 Roquette Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roquette Main Business Overview
13.1.5 Roquette Latest Developments
13.2 Nihon Shokuhin Kako
13.2.1 Nihon Shokuhin Kako Company Information
13.2.2 Nihon Shokuhin Kako Beta-Cyclodextrin Product Portfolios and Specifications
13.2.3 Nihon Shokuhin Kako Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nihon Shokuhin Kako Main Business Overview
13.2.5 Nihon Shokuhin Kako Latest Developments
13.3 Shandong Xinda
13.3.1 Shandong Xinda Company Information
13.3.2 Shandong Xinda Beta-Cyclodextrin Product Portfolios and Specifications
13.3.3 Shandong Xinda Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shandong Xinda Main Business Overview
13.3.5 Shandong Xinda Latest Developments
13.4 Zibo Qianhui
13.4.1 Zibo Qianhui Company Information
13.4.2 Zibo Qianhui Beta-Cyclodextrin Product Portfolios and Specifications
13.4.3 Zibo Qianhui Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zibo Qianhui Main Business Overview
13.4.5 Zibo Qianhui Latest Developments
13.5 Mengzhou Huaxing
13.5.1 Mengzhou Huaxing Company Information
13.5.2 Mengzhou Huaxing Beta-Cyclodextrin Product Portfolios and Specifications
13.5.3 Mengzhou Huaxing Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mengzhou Huaxing Main Business Overview
13.5.5 Mengzhou Huaxing Latest Developments
13.6 Mengzhou Hongji
13.6.1 Mengzhou Hongji Company Information
13.6.2 Mengzhou Hongji Beta-Cyclodextrin Product Portfolios and Specifications
13.6.3 Mengzhou Hongji Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mengzhou Hongji Main Business Overview
13.6.5 Mengzhou Hongji Latest Developments
13.7 Zhiyuan Biotechnology
13.7.1 Zhiyuan Biotechnology Company Information
13.7.2 Zhiyuan Biotechnology Beta-Cyclodextrin Product Portfolios and Specifications
13.7.3 Zhiyuan Biotechnology Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zhiyuan Biotechnology Main Business Overview
13.7.5 Zhiyuan Biotechnology Latest Developments
13.8 Jiyan Chemicals And Pharmaceuticals
13.8.1 Jiyan Chemicals And Pharmaceuticals Company Information
13.8.2 Jiyan Chemicals And Pharmaceuticals Beta-Cyclodextrin Product Portfolios and Specifications
13.8.3 Jiyan Chemicals And Pharmaceuticals Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiyan Chemicals And Pharmaceuticals Main Business Overview
13.8.5 Jiyan Chemicals And Pharmaceuticals Latest Developments
13.9 W＆Z Biotech
13.9.1 W＆Z Biotech Company Information
13.9.2 W＆Z Biotech Beta-Cyclodextrin Product Portfolios and Specifications
13.9.3 W＆Z Biotech Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 W＆Z Biotech Main Business Overview
13.9.5 W＆Z Biotech Latest Developments
13.10 Henrikang Biotech
13.10.1 Henrikang Biotech Company Information
13.10.2 Henrikang Biotech Beta-Cyclodextrin Product Portfolios and Specifications
13.10.3 Henrikang Biotech Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Henrikang Biotech Main Business Overview
13.10.5 Henrikang Biotech Latest Developments
13.11 Cyclo Therapeutics
13.11.1 Cyclo Therapeutics Company Information
13.11.2 Cyclo Therapeutics Beta-Cyclodextrin Product Portfolios and Specifications
13.11.3 Cyclo Therapeutics Beta-Cyclodextrin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cyclo Therapeutics Main Business Overview
13.11.5 Cyclo Therapeutics Latest Developments
14 Research Findings and Conclusion